Safety and Efficacy of His Bundle Pacing Validated by Extracardiac Vagal Nerve Stimulation
HIS-STORY
Safety and Efficacy of HIs Bundle Pacing Validated by electrophySiological STudy, autonOmic Tests and extRacardiac Vagal Nerve Stimulation (HIS-STORY)
1 other identifier
interventional
60
1 country
3
Brief Summary
Different studies for extracardiac vagal nerve stimulation (ECANS) have been published and confirmed the influence of the vagus nerve on automaticity and conduction properties of the sinus node, atria, atrioventricular node, as well as the His-Purkinje system (HPS) and ventricles. However, there are limited data on the clinical value and impact of ECANS as well as vagus nerve activity on the parameters of permanent His-bundle (HB) or left bundle branch (LBB) pacing. Moreover, there have been no prospective studies evaluating the feasibility and efficacy of ECANS and the management of ECANS-induced scenarios, such as an exit block, increase in pacing threshold, as well as vagally mediated arrhythmias and conduction abnormalities in patients with physiological conduction system pacing (HB/LBB pacing). The objective of the HIS-STORY study in humans is to evaluate the clinical value of ECANS in patients with HB/LBB pacing for further development of patient-centered management strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2021
CompletedFirst Submitted
Initial submission to the registry
March 21, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedDecember 20, 2022
December 1, 2022
3 years
March 21, 2021
December 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Loss of HB/LBB capture or significant increase in pacing threshold
significant increase in pacing threshold = above the permanently programmed impulse amplitude of HB/LBB electrode induced by ECANS
0-12 months after HB/LBB pacemaker implantation
Secondary Outcomes (2)
A nonsignificant increase in pacing threshold
0-12 months after HB/LBB pacemaker implantation
Prolongation of the stimulus-QRS interval during HB/LBB pacing induced by ECANS
0-12 months after HB/LBB pacemaker implantation
Other Outcomes (1)
Any arrhythmia induced by ECANS
0-12 months after HB/LBB pacemaker implantation
Study Arms (2)
ECANS started from the right vagus nerve
ACTIVE COMPARATORsuperior ECANS and ultrasonography guided inferior ECANS
ECANS started from the left vagus nerve
ACTIVE COMPARATORsuperior ECANS and ultrasonography guided inferior ECANS
Interventions
The study intervention will consist of 3 steps, all of which will be performed under general anesthesia: 1. EPS with the measurement of parameters of atrioventricular conduction and programmed atrial and ventricular pacing. 2. ECANS of the right and the left vagus nerve (from the right and left internal jugular vein, respectively; patients will be randomized to start from the right or the left side) performed during: 1) the patient's spontaneous heart rhythm (if present); 2) HB/LBB pacing with permanently programmed impulse parameters; 3) HB/LBB pacing at a pacing threshold of +0.1 V; and 4) 5 minutes after intravenous injection of atropine (0.02-0.04 mg/kg). 3. EPS with the measurement of parameters of atrioventricular conduction and programmed atrial and ventricular pacing.
Eligibility Criteria
You may qualify if:
- signed informed consent form
- effective and stable HB or LBB pacing
- sinus rhythm during the intervention procedure
You may not qualify if:
- contraindications to invasive EPS
- contraindications to general anesthesia
- contraindications to atropine administration (e.g., glaucoma)
- persistent atrial fibrillation or atrial flutter
- pregnancy
- diseases that may cause autonomic system neuropathy
- use of medications that may affect the parasympathetic system
- a history of cardiac surgery
- a history of ablation due to arrhythmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- 4th Military Clinical Hospital with Polyclinic, Polandlead
- Subcarpathian Center for Cardiovascular Interventioncollaborator
- Mazovian Speciality Hospitalcollaborator
- Wroclaw Medical Universitycollaborator
Study Sites (3)
4th Military Hospital, Cardiology Department
Wroclaw, Lower Silesian Voivodeship, 50-981, Poland
Mazovian Speciality Hospital, Cardiology Department
Radom, Masovian Voivodeship, 26-617, Poland
Subcarpathian Center for Cardiovascular Intervention
Sanok, Podkarpackie Voivodeship, 38-500, Poland
Related Publications (10)
Abdelrahman M, Subzposh FA, Beer D, Durr B, Naperkowski A, Sun H, Oren JW, Dandamudi G, Vijayaraman P. Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. J Am Coll Cardiol. 2018 May 22;71(20):2319-2330. doi: 10.1016/j.jacc.2018.02.048. Epub 2018 Mar 10.
PMID: 29535066RESULTKronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014 Aug;16(8):1189-96. doi: 10.1093/europace/euu011. Epub 2014 Feb 7.
PMID: 24509688RESULTDandamudi G, Vijayaraman P. How to perform permanent His bundle pacing in routine clinical practice. Heart Rhythm. 2016 Jun;13(6):1362-6. doi: 10.1016/j.hrthm.2016.03.040. Epub 2016 Mar 22. No abstract available.
PMID: 27016475RESULTJosiak K, Nowak K, Fuglewicz A, Jagielski D, Banasiak W, Ponikowski P. Does right ventricular pacing increase the risk of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator? Kardiol Pol. 2014;72(4):381-4. doi: 10.5603/KP.2014.0073. No abstract available.
PMID: 24733700RESULTSharma PS, Dandamudi G, Naperkowski A, Oren JW, Storm RH, Ellenbogen KA, Vijayaraman P. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 2015 Feb;12(2):305-12. doi: 10.1016/j.hrthm.2014.10.021. Epub 2014 Oct 22.
PMID: 25446158RESULTBurri H, Jastrzebski M, Vijayaraman P. Electrocardiographic Analysis for His Bundle Pacing at Implantation and Follow-Up. JACC Clin Electrophysiol. 2020 Jul;6(7):883-900. doi: 10.1016/j.jacep.2020.03.005.
PMID: 32703577RESULTZysko D, Gajek J, Kozluk E, Mazurek W. Electrocardiographic characteristics of atrioventricular block induced by tilt testing. Europace. 2009 Feb;11(2):225-30. doi: 10.1093/europace/eun299. Epub 2008 Nov 5.
PMID: 18987129RESULTKlank-Szafran M, Stec S, Sledz J, Janion M. [Radiofrequency ablation and cardioneuroablation for AVNRT and atrioventricular block]. Kardiol Pol. 2010 Jun;68(6):720-4. Polish.
PMID: 20806214RESULTPachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005 Jan;7(1):1-13. doi: 10.1016/j.eupc.2004.10.003.
PMID: 15670960RESULTStec S, Dobaj L, Sledz A, Stepien-Walek AM, Ton V, Sledz J. Cardioneuroablation for management of cardioinhibitory vasovagal syncope and pacemaker complications. HeartRhythm Case Rep. 2020 May 11;6(8):531-534. doi: 10.1016/j.hrcr.2020.04.021. eCollection 2020 Aug. No abstract available.
PMID: 32817835RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Krystian Josiak, MD, PhD
4th Military Clinical Hospital with Polyclinic, Poland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Krystian Josiak, MD, PhD
Study Record Dates
First Submitted
March 21, 2021
First Posted
March 25, 2021
Study Start
January 2, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
December 20, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share